The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
Open accessAbstract
BACKGROUND: In patients with multivessel coronary artery disease who are undergoing percutaneous coronary intervention (PCI), coronary angiography is the standard method for guiding the placement of the stent. It is unclear whether routine measurement of fractional flow reserve (FFR; the ratio of maximal blood flow in a stenotic artery to normal maximal flow), in addition to angiography, improves outcomes. METHODS: In 20 medical centers in the United States and Europe, we randomly assigned 1005 patients with multivessel coronary artery disease to undergo PCI with implantation of drug-eluting stents guided by angiography alone or guided by FFR measurements in addition to angiography. Before randomization, lesions requiring PCI were identified on the basis of their angiographic appearance. Patients assigned to angiography-guided PCI underwent stenting of all indicated lesions, whereas those assigned to FFR-guided PCI underwent stenting of indicated lesions only if the FFR was 0.80 or less. The primary end point was the rate of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. RESULTS: The mean (+/-SD) number of indicated lesions per patient was 2.7+/-0.9 in the angiography group and 2.8+/-1.0 in the FFR group (P=0.34). The number of stents used per patient was 2.7+/-1.2 and 1.9+/-1.3, respectively (P<0.001). The 1-year event rate was 18.3% (91 patients) in the angiography group and 13.2% (67 patients) in the FFR group (P=0.02). Seventy-eight percent of the patients in the angiography group were free from angina at 1 year, as compared with 81% of patients in the FFR group (P=0.20). CONCLUSIONS: Routine measurement of FFR in patients with multivessel coronary artery disease who are undergoing PCI with drug-eluting stents significantly reduces the rate of the composite end point of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. (ClinicalTrials.gov number, NCT00267774.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699 · cited 2×
“Patients who had undergone previous PCI were included in the present study, which is often not the case in randomized trials of coronary revascularization.(6,34,37)”
BackgroundMethodUniversal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
Pijls, N. H. J., de Bruyne, B., Peels, K., van der Voort, P. H., Bonnier, H. J. R. M., Bartunek, J., & Koolen, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342604 · Cited by 2,321
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
Shaw, L. J., Berman, D. S., Maron, D. J., Mancini, G. B. J., Hayes, S. W., Hartigan, P. M., Weintraub, W. S., O’Rourke, R. A., Dada, M., Spertus, J. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.743963 · Cited by 1,605
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis
Pijls, N. H. J., van Schaardenburgh, P., Manoharan, G., Boersma, E., Bech, J.-W., van’t Veer, M., Bär, F., Hoorntje, J., Koolen, J., Wijns, W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.087 · Cited by 1,516
Self-citationLate Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Pijls, N. H., van Son, J. A., Kirkeeide, R. L., De Bruyne, B., & Gould, K. L. (1993) · Circulation · doi:10.1161/01.cir.87.4.1354 · Cited by 1,183
Self-citationComparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
Serruys, P. W., Unger, F., Sousa, J. E., Jatene, A., Bonnier, H. J. R. M., Schönberger, J. P. A. M., Buller, N., Bonser, R., van den Brand, M. J. B., van Herwerden, L. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441502 · Cited by 1,114
Topol, E. J., & Nissen, S. E. (1995) · Circulation · doi:10.1161/01.cir.92.8.2333 · Cited by 1,103
Prognostic value of gated myocardial perfusion SPECT
Shaw, L. J., & Iskandrian, A. E. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2003.12.004 · Cited by 661
Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease
Hannan, E. L., Wu, C., Walford, G., Culliford, A. T., Gold, J. P., Smith, C. R., Higgins, R. S. D., Carlson, R. E., & Jones, R. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071804 · Cited by 541
UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
Thygesen, K., Alpert, J., & White, H. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-5-91-105 · Cited by 525
Davies, R. F., Goldberg, A. D., Forman, S., Pepine, C. J., Knatterud, G. L., Geller, N., Sopko, G., Pratt, C., Deanfield, J., & Conti, C. R. (1997) · Circulation · doi:10.1161/01.cir.95.8.2037 · Cited by 461
Lima, R. S. L., Watson, D. D., Goode, A. R., Siadaty, M. S., Ragosta, M., Beller, G. A., & Samady, H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00562-x · Cited by 415
Beller, G. A., & Zaret, B. L. (2000) · Circulation · doi:10.1161/01.cir.101.12.1465 · Cited by 404
Fractional Flow Reserve in Patients With Prior Myocardial Infarction
De Bruyne, B., Pijls, N. H. J., Bartunek, J., Kulecki, K., Bech, J.-W., De Winter, H., Van Crombrugge, P., Heyndrickx, G. R., & Wijns, W. (2001) · Circulation · doi:10.1161/01.cir.104.2.157 · Cited by 386
Self-citationClinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
Win, H. K., Caldera, A. E., Maresh, K., Lopez, J., Rihal, C. S., Parikh, M. A., Granada, J. F., Marulkar, S., Nassif, D., Cohen, D. J., et al. (2007) · JAMA · doi:10.1001/jama.297.18.2001 · Cited by 343
Kaiser, C., Brunner-La Rocca, H. P., Buser, P. T., Bonetti, P. O., Osswald, S., Linka, A., Bernheim, A., Zutter, A., Zellweger, M., Grize, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67221-2 · Cited by 342
Ong, A. T. L., Serruys, P. W., Mohr, F. W., Morice, M.-C., Kappetein, A. P., Holmes, D. R., Mack, M. J., van den Brand, M., Morel, M.-A., van Es, G.-A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.017 · Cited by 338
Hannan, E. L., Racz, M., Holmes, D. R., King, S. B., Walford, G., Ambrose, J. A., Sharma, S., Katz, S., Clark, L. T., & Jones, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.612267 · Cited by 311
Erne, P., Schoenenberger, A. W., Burckhardt, D., Zuber, M., Kiowski, W., Buser, P. T., Dubach, P., Resink, T. J., & Pfisterer, M. (2007) · JAMA · doi:10.1001/jama.297.18.1985 · Cited by 311
Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suárez de Lezo, J., Goy, J.-J., Ulm, K., & Schömig, A. (2005) · JAMA · doi:10.1001/jama.294.7.819 · Cited by 282
Kastrati, A., Dibra, A., & Eberle, S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.10.047 · Cited by 235
Fischer, J. J., Samady, H., McPherson, J. A., Sarembock, I. J., Powers, E. R., Gimple, L. W., & Ragosta, M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02456-6 · Cited by 234
PFISTERER, M. E., Rocca, H. B., Buser, P. T., Rickenbacher, P. R., Hunziker, P., Mueller, C., Jeger, R. V., Bader, F., Osswald, S., & Kaiser, C. (2006) · Cited by 143
Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two Years
Ong, A. T. L., van Domburg, R. T., Aoki, J., Sonnenschein, K., Lemos, P. A., & Serruys, P. W. J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.102 · Cited by 80
Drug-Eluting Stents in the Treatment of Intermediate Lesions
Moses, J. W., Stone, G. W., Nikolsky, E., Mintz, G. S., Dangas, G., Grube, E., Ellis, S. G., Lansky, A. J., Weisz, G., Fahy, M. P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.068 · Cited by 70
Cited by
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Metadata
- Authors
- Tonino, P. A. L., De Bruyne, B., Pijls, N. H. J., Siebert, U., Ikeno, F., van `t Veer, M., Klauss, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., Ver Lee, P. N., MacCarthy, P. A., & Fearon, W. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-01-15
- Volume
- 360
- Issue
- 3
- Pages
- 213-224
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2115416118
- Cited by
- 4,260
- References
- 30
- FWCI
- 192.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.